| Literature DB >> 25567972 |
Abstract
Many evolutionary applications in medicine rely on well-established methods, such as population genetics, phylogenetic analysis, and observing pathogen evolution. Approaches to evolutionary questions about traits that leave bodies vulnerable to disease are less well developed. Strategies for formulating questions and hypotheses remain unsettled, and methods for testing evolutionary hypotheses are unfamiliar to many in medicine. This article uses recent examples to illustrate successful strategies and some common challenges. Ten questions arise in the course of considering hypotheses about traits that leave bodies vulnerable to disease. Addressing them systematically can help minimize confusion and errors.Entities:
Keywords: Darwinian medicine; disease; evolutionary medicine; hypothesis testing; methodology; vulnerability
Year: 2011 PMID: 25567972 PMCID: PMC3352562 DOI: 10.1111/j.1752-4571.2010.00181.x
Source DB: PubMed Journal: Evol Appl ISSN: 1752-4571 Impact factor: 5.183
Ten questions for evolutionary studies of disease vulnerability
| Q1. Is the object of explanation a uniform trait in the species, or is the goal to explain variations in a trait among groups or individuals? |
| Q2. Has the object of explanation been influenced by evolution? |
| Q3. What kind of trait is the object of explanation? |
| a. A fixed human trait, such as the narrow birth canal |
| b. A facultative trait, such as the capacity for sweating |
| c. Human genes, in the most general sense of the term |
| d. Pathogen traits, such as the level of virulence |
| e. Pathogen genes, such as those that confer antibiotic resistance |
| f. Somatic cell lines, such as those in tumors or the immune system |
| Q4. Is the goal to explain the evolution of the trait, or its proximate mechanisms? |
| Q5. Is the goal to explain the trait's phylogeny, or the evolutionary forces that shaped it? |
| Q6. Are all viable hypotheses considered and given fair consideration, or are some hypotheses neglected, while others receive favored treatment? |
| Q7. Could different vulnerabilities cause the disease in different individuals or subgroups? |
| Q8. What categories of explanation are under consideration? |
| a. Mismatch of bodies with environments they did not evolve in |
| b. Co-evolution with pathogens that evolve faster than hosts can |
| c. Constraints on selection, such as time required, genetic drift, and mutation |
| d. Trade-offs, especially costs associated with apparently superior alternative possible traits |
| e. Reproductive success at the expense of health |
| f. Defenses such as fever and pain that cause harm and suffering, but were shaped by selection because they offer protection in certain situations |
| Q9. Could multiple explanations be correct? |
| Q10. What methods are used to test the hypotheses? |
| a. Consistency with evolutionary theory |
| b. Modeling using quantitative methods |
| c. Comparative methods |
| i. Comparisons among species |
| ii. Comparisons among subgroups of a species |
| iii. Comparisons among individuals who vary in a trait |
| d. Experimental methods |
| i. Extirpation or disruption (e.g. studies that knock-out genes or block fever) |
| ii. Augmentation (e.g. administration of extra testosterone) |
| iii. Examining regulation of a facultative trait to see if it behaves as predicted |
| iv. Observing evolutionary changes in the lab or the field |
| e. Examining the details of fit between observed form and a postulated function |
Evolutionary explanations for high frequencies of disease-causing alleles (Valles 2010, 185)
| 1 | Elevated mutation rate |
| 2 | Segregation distortion |
| 3 | Reproductive compensation |
| 4 | Founder effects and genetic drift |
| 5 | Heterozygote advantage (overdominance) |